A new article, published this month in Diabetes Therapy, provides a comprehensive review of the OmniPod Insulin Management System (Insulet Corp., Bedford MA, USA) (NASDAQ: PODD) — an automated, tube-free insulin pump that can be controlled wirelessly through a handheld device containing an integrated blood glucose meter. From there, I jumped back and forth between my out of warranty backup pump (the Cozmo 1800) and my brand new shiny Tandem tslim (that hasn’t worked out for me). I explained to her that the cannula failed to insert itself for the second time in a one-month span. OmniPod System Overview: Gain insight into the way the insulin pumping System works—and how it can make diabetes a smaller part of your life. I’m thinking of the omnipod because it’s tubeless . This new delivery system represents an opportunity for diabetes patients with higher insulin requirements to benefit from the improved glycemic control compared to multiple daily injections and ease of use that Insulet’s OmniPod System provides. Fortunately for me, I experienced less than a handful of pod failures in my first year in a half of using the OmniPod.
Keep in mind that my biggest personal barrier to pump therapy is an aversion to the idea of having a boxy unit hanging off my body via a bunch of plastic tubing. The Company’s first artificial pancreas system will rely on the unique Omnipod platform coupled with the latest DexCom CGM technology and will be powered by the algorithm licensed from Mode AGC in February 2016. Wel het koud biertje daarna. In an attempt to somewhat fill in this “gap” in coverage, and reduce the dangerous peaking action which had been caused numerous severe Hypoglycemic episodes at night, we all agreed to try switching Tim’s daily Lantus dose into two shots, 12 hours apart. I injected short acting insulin when I ate a meal or anything with carbohydrates. One of the best parts of CGM is the addition of a trend arrow to single blood glucose points, which add contextual information to improve decision-making. Insulet Corporation (NASDAQ: PODD) is an innovative medical device company dedicated to making the lives of people with diabetes easier.
Through its Omnipod Insulin Management System, Insulet seeks to expand the use of insulin pump therapy among people with insulin-dependent diabetes. The small, light-weight Pod can be worn in multiple locations, including the abdomen, hip, back of upper arm, upper thigh or lower back and, because it is waterproof (IPX8), there is no need to remove when showering, swimming or performing other activities. So no one even needs to know you’re wearing an insulin pump. Tick, tick, tick…while it’s reassuring to me that my pod is dispensing insulin, it’s something that I’d like to tune out. To this point I had been holding my shit together. Founded in 2000, Insulet Corporation is based in Billerica, Massachusetts. This press release may contain forward-looking statements concerning Insulet’s expectations, anticipations, intentions, beliefs or strategies regarding the future.
These forward-looking statements are based on its current expectations and beliefs concerning future developments and their potential effects on Insulet. For one thing, you can easily print out an OmniPod PDM Settings Report, which shows all your basal segments, IC ratio, correction factor, etc., etc. Insulet undertakes no obligation to publicly update or revise any forward-looking statements. Should one or more of these risks or uncertainties materialize, or should any of its assumptions prove incorrect, actual results may vary in material respects from those projected in these forward-looking statements. Insulet undertakes no obligation to publicly update or revise any forward-looking statements.